Alx Oncology HoldingsÂ (ALXO) Financials

$1.69

$-0.05 (-2.79%)

As on 18-Sep-2026 13:32EDT

Market cap

$268 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	0.15	--	0.87	0.84	1.47	0.74
Gross Profit	-0.15	--	-0.87	-0.84	-1.47	-0.74
Operating Expenses	82.40	104.02	142.47	170.28	127.44	83.56
Operating Profit (EBIT)	-82.55	-104.02	-142.47	-170.28	-127.44	-83.56
Other Income	--	--	--	--	-0.26	0.08
Profit before Tax	-80.89	-101.70	-134.85	-160.81	-123.42	-83.48
Provision for Tax	--	--	--	--	0.06	-0.02
Profit after Tax (Net Income)	-80.89	-101.70	-134.85	-160.81	-123.48	-83.46
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-123.48	-83.46

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	136.19	25.98	113.62	189.71	263.46	363.05
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	9.86	8.51	15.66	16.84	14.70	1.84
Current Liabilities	14.78	24.55	18.50	36.00	28.33	15.30
Total Liabilities	175.60	59.05	147.78	242.55	306.49	380.18

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	17.36	8.32	13.42	53.89	35.52	13.16
Current Assets	143.46	50.73	134.35	188.66	270.97	367.02
Total Assets	175.60	59.05	147.78	242.55	306.49	380.18
Total Debt*	9.71	5.22	16.98	17.20	10.43	0.74
Net Current Assets	128.68	26.17	115.85	152.66	242.64	351.72

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-84.14	-121.91	-130.36	-89.22	-68.10
Cash Flow from Investing Activities	--	82.59	86.26	44.66	-235.42	-4.92
Cash from Financing Activities	--	0.36	30.82	59.29	9.86	2.47
Net Cash Inflow / Outflow	--	--	--	--	-314.78	-70.55

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.14	-1.87	-2.55	-3.28	-3.03	-2.06
Cash EPS ($)	--	-1.86	-2.54	-3.26	-3.02	-2.06
Adjusted Book Value ($)	--	0.48	2.15	3.87	6.46	8.96
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.55	-2.31	-2.66	-2.19	-1.68
Free Cash Flow per Share ($)	--	-1.55	-2.32	-2.69	-2.22	-1.80

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-125.71	-79.91	-66.89	-38.73	-21.03
ROE (%)	-99.76	-145.70	-88.91	-70.97	-39.42	-21.05
ROA (%)	-55.83	-98.34	-69.10	-58.58	-35.97	-20.45
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	47,493.08	-99,360.71
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	-1.00
EBIT Growth (%)	30.82	24.81	16.40	-24.96	-52.67	-91.17
Net Profit Growth (%)	30.61	24.59	16.14	-30.23	-47.95	-82.47
EPS Growth (%)	48.19	0.27	0.22	-0.08	-0.47	-0.69
Book Value Growth (%)	-16.69	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.60	-0.65	-4.54	-3.72	-10.43
Price / Book Value	1.92	2.36	0.78	3.85	1.74	2.40
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-2.35	-0.22	0.17	-3.56	-1.60	-6.09
Close Price ($)	2.07	1.13	1.67	14.89	11.27	21.49
High Price ($)	2.66	2.27	17.83	15.92	22.50	91.52
Low Price ($)	0.41	0.40	1.19	3.94	5.82	20.31
Market Cap ($ Cr)	268.26	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	0.07	0.20	0.15	0.09	0.04	0.00
Short term debt to equity ratio	--	0.20	0.02	0.01	0.00	0.00
Current Ratio	9.71	2.07	7.26	5.24	9.57	24.00
Quick Ratio	9.71	--	--	--	10.19	--
Interest Coverage	-56.49	-62.48	-76.99	-101.75	-29.23	-6,420.85

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	-7,732.73	-4,409.66	--
Payable days	--	--	2,741.05	3,640.27	1,474.58	934.96
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.